A study of the central effects of 5,6-dihydroxytryptamine.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001679:Biogenic Amines / Q000378:metabolism; D001921:Brain / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D004567:Electrodes, Implanted; D004569:Electroencephalography; D005260:Female; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D013997:Time Factors; D014363:Tryptamines / Q000494:pharmacology*
D001679:Biogenic Amines; D006892:Hydroxydopamines; D014363:Tryptamines; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D010293:Pargyline; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine